| |
| |
|
| Insider
Information: |
Fonteyne Paul R. |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
74,217 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$820,665 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
74,217 |
|
|
| Total
Value |
$820,665 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Director |
2020-11-16 |
0 |
2019-10-08 |
0 |
Premium* |
|
|
Apellis Pharmaceuticals Inc |
APLS |
Director |
2024-01-01 |
16,438 |
2020-05-08 |
0 |
Premium* |
|
|
Covetrus, Inc. |
CVET |
Director |
2022-10-13 |
0 |
2021-08-10 |
0 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
Director |
2022-01-06 |
3,947 |
2022-01-06 |
0 |
Premium* |
|
|
Gelesis Holdings Ord Shs |
GLS |
Director |
2022-05-06 |
53,832 |
2022-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,341 |
16,438 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
– • – |
2023-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,867 |
13,097 |
0 |
- |
|
| CVET |
Covetrus, Inc. |
Director |
– • – |
2022-10-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,275) |
0 |
0 |
- |
|
| CVET |
Covetrus, Inc. |
Director |
– • – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,275 |
13,275 |
0 |
- |
|
| GLS |
Gelesis Holdings Ord Shs |
Director |
– • – |
2022-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
53,832 |
53,832 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Director |
– • – |
2022-01-06 |
4 |
B |
$19.00 |
$74,993 |
D/D |
3,947 |
3,947 |
2.39 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2022-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,230 |
9,230 |
0 |
- |
|
| CVET |
Covetrus, Inc. |
Director |
– • – |
2021-08-10 |
4 |
B |
$23.24 |
$116,200 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,676) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2020-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,269 |
14,676 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Director |
• • – |
2020-05-08 |
4 |
B |
$31.81 |
$159,034 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Director |
– • – |
2019-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,407 |
4,407 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
